We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
Cap. Flow
+$34.9M
Cap. Flow %
3.23%
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47

Top Buys

Rank Stock Value
1
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$8.46M
2
HA
Hawaiian Holdings, Inc.
HA
+$8.23M
3
LM
Legg Mason, Inc.
LM
+$7.93M
4
CHSP
Chesapeake Lodging Trust
CHSP
+$7.89M
5
COKE icon
Coca-Cola Consolidated
COKE
+$7.73M

Top Sells

Rank Stock Value
1
KCG
KCG Holdings, Inc.
KCG
+$9.43M
2
MGLN
Magellan Health Services, Inc.
MGLN
+$8.69M
3
PLUS icon
ePlus
PLUS
+$8.06M
4
MUSA icon
Murphy USA
MUSA
+$7.57M
5
THO icon
Thor Industries
THO
+$7.4M

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Industrials 15.81%
3 Technology 13.65%
4 Consumer Discretionary 11.93%
5 Healthcare 11.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYY icon
126
Sysco
SYY
$39.7B
$3.82M 0.35%
75,985
+11,653
+18% +$622K
SHW icon
127
Sherwin-Williams
SHW
$78.3B
$3.81M 0.35%
+32,526
New +$3.63M
UNH icon
128
UnitedHealth
UNH
$382B
$3.77M 0.35%
20,312
+408
+2% +$71.5K
MNTA
129
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.73M 0.35%
220,913
+116,538
+112% +$1.77M
WMB icon
130
Williams Companies
WMB
$90.5B
$3.67M 0.34%
121,076
+18,644
+18% +$555K
ESND
131
DELISTED
Essendant Inc.
ESND
$3.58M 0.33%
241,563
+59,656
+33% +$942K
SEM
132
DELISTED
Select Medical
SEM
$3.47M 0.32%
419,864
-28,317
-6% -$213K
DYN
133
DELISTED
Dynegy, Inc.
DYN
$3.34M 0.31%
404,443
+37,830
+10% +$286K
GCAP
134
DELISTED
Gain Capital Holdings, Inc.
GCAP
$3.22M 0.3%
516,441
+423,209
+454% +$2.75M
DRH icon
135
Diamondrock Hospitality Co
DRH
$2.63B
$3.14M 0.29%
287,129
+6,430
+2% +$71.9K
ERF
136
DELISTED
Enerplus Corporation
ERF
$3.01M 0.28%
370,113
-36,768
-9% -$290K
SNCR
137
DELISTED
Synchronoss Technologies
SNCR
$3M 0.28%
20,255
-7,255
-26% -$1.08M
FICO icon
138
Fair Isaac
FICO
$28.7B
$2.98M 0.28%
21,375
+410
+2% +$54.8K
RM icon
139
Regional Management Corp
RM
$384M
$2.87M 0.27%
121,300
-6,866
-5% -$144K
CLS icon
140
Celestica
CLS
$35.1B
$2.86M 0.26%
210,540
-2,965
-1% -$41.6K
FTD
141
DELISTED
FTD Companies, Inc. Common Stock
FTD
$2.84M 0.26%
142,025
+51,163
+56% +$986K
BSTC
142
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.82M 0.26%
57,034
-2,244
-4% -$118K
KFRC icon
143
Kforce
KFRC
$983M
$2.82M 0.26%
143,747
+3,357
+2% +$67.5K
SIR
144
DELISTED
SELECT INCOME REIT
SIR
$2.8M 0.26%
265,076
-988
-0.4% -$10.8K
BMTC
145
DELISTED
Bryn Mawr Bank Corp
BMTC
$2.77M 0.26%
65,203
+2,323
+4% +$96K
PTCT icon
146
PTC Therapeutics
PTCT
$6.37B
$2.76M 0.26%
150,601
+132,288
+722% +$1.78M
WIRE
147
DELISTED
Encore Wire Corp
WIRE
$2.71M 0.25%
63,540
+1,522
+2% +$65.4K
LNW
148
DELISTED
Light & Wonder
LNW
$2.68M 0.25%
102,678
+51,303
+100% +$1.22M
ALTO icon
149
Alto Ingredients
ALTO
$360M
$2.57M 0.24%
+411,823
New +$2.67M
CRVL icon
150
CorVel
CRVL
$3.05B
$2.53M 0.23%
159,999
+6,498
+4% +$98.4K
4 5
6
7 8

Similar funds

GBBWRPM
Genovese Burford & Brothers Wealth & Retirement Plan Management Sacramento, California $400M AUM 14.87% 1-Year Est. Return
PSSGI
P-STS SPV GP IA San Francisco, California $433M AUM
RA
Reby Advisors Danbury, Connecticut $382M AUM
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
SIVVM
SC Israel Venture V Management Herzelia, Israel $373M AUM
SM
Scale Management Foster City, California $359M AUM
NFG
NewFocus Financial Group Vancouver, Washington $340M AUM 17.91% 1-Year Est. Return
AWW
Alan W. Weber $336M AUM 75.94% 1-Year Est. Return

Matarin Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.

  • Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
  • Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
  • Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
  • Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
  • Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
  • Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
  • Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.

Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.